Research and Development

Showing 15 posts of 9596 posts found.

Gilead names Roche veteran Daniel O’Day as new CEO

December 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Gilead, Roche, appointment

Almost half a year since it was revealed that Gilead’s Dr John Milligan would be stepping down from his role …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Cancer, Diagnostics, Sanofi, Takeda, brexit

Takeda’s acquisition of Shire finally got the go-ahead this week as 88% of shareholders voted in favour of French CEO …
jeffrey_hackman

EUSA Pharma take on Novelion CEO Jeffrey Hackman to lead US expansion

December 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Hertfordshire-based speciality pharma firm EUSA Pharma has appointed Jeffrey S Hackman as President of the company’s United States operations. …

UCB to invest £1 billion into UK R&D

December 6, 2018 Manufacturing and Production, Research and Development R&D, UCB, UK, brussels, investment, research

The Brussels-based multinational UCB will invest £1 billion into UK research and development, according to the government’s Life Sciences Sector …

British researchers sequences 100,000 whole genomes

December 6, 2018 Research and Development Matt Hancock, digital, genome, personalised medicnie

British researchers have sequenced 100,000 whole genomes as part of an effort to improve understanding of rare diseases and move …

Working Life: Kai Gait, Senior Global Digital Director at GlaxoSmithKline

December 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, GSK, Interview, UK, US, digital, senior global director, technology

Kai Gait, Senior Global Digital Director at GlaxoSmithKline, retraces the steps that have led him to where he is today, …
amgen_flag

Amgen unveils double whammy of data for its investigational cancer immunotherapies at ASH 2018

December 5, 2018 Research and Development ASH 2018, Amgen, Cancer, acute myeloid leukaemia, myeloma, pharma

Amgen has presented the first clinical data at the American Society of Hematology (ASH) Annual Meeting 2018 for two investigational …
acute_leukemia-all

New diagnostic test can detect any cancer type in minutes with 90% accuracy

December 5, 2018 Research and Development Australia, Cancer, pharma

Researchers at the University of Queensland have a test which can rapidly detect the presence of cancer in a patient’s …
shutterstock_212432119

UK Government announces first-of-its-kind Vaccines Manufacturing Innovation Centre

December 5, 2018 Research and Development UK, pharma, vaccines

Plans for a Vaccines Manufacturing Innovation Centre in the UK have been unveiled by Business Secretary Greg Clark, in a …
rocherooflr

Roche’s first-line Tecentriq combo scores accelerated FDA review

December 5, 2018 Research and Development ASH 2018, Cancer, Roche, lung cancer, pharma, tecentriq

Roche’s immunotherapy Tecentriq has secured Priority Review from the FDA, the company has announced, in combination with carboplatin and etoposide …
janssen_latest_logo_on_sign_closer

Darzalex “significantly reduces” disease progression and death in multiple myeloma at ASH 2018

December 5, 2018 Research and Development ASH 2018, Janssen, darzalex, multiple myeloma, pharma

Janssen has taken the opportunity at the American Society of Hematology (ASH) Annual Meeting 2018 to unveil new Phase 3 …

Pfizer’s biosimilar proves non-inferior to rituximab in lymphoma at ASH 2018

December 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASH 2018, Pfizer, haemophilia

Joining the chorus of data presentations at the American Society of Hematology (ASH) Annual Meeting 2018, Pfizer has announced new …
shutterstock_243110086

Hemlibra shows “clinically meaningful” bleed control in paediatric haemophilia A patients

December 4, 2018 Manufacturing and Production, Research and Development ASH 2018, Hemlibra, Roche, haemophilia, pharma

In another reveal at the American Society of Hematology (ASH) Annual Meeting 2018, Roche unveiled new Phase 3 findings for …
institute_of_cancer_research

Cancer drug access for NHS patients is slowing, ICR reports

December 4, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Cancer, ICR, Institute of Cancer Research, NHS, NICE, UK, pharma

A new report from the Institute of Cancer Research (ICR) has indicated that NHS patients in the UK are suffering …
The Gateway to Local Adoption Series

Latest content